Fuller & Thaler Asset Management
INDV icon

Fuller & Thaler Asset Management’s Indivior Pharmaceuticals INDV Stock Holding History

Fuller & Thaler Asset Management’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$189M Buy
4,615,816
+86,233
+2% +$3.13M 0.52% 56
2026
Q1 		$138M Sell
4,529,583
-1,841,951
-29% -$60.8M 0.46% 77
2025
Q4 		$229M Buy
6,371,534
+3,201,639
+101% +$97.8M 0.77% 22
2025
Q3 		$76.4M Buy
+3,169,895
New +$66.3M 0.26% 137

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

Fuller & Thaler Asset Management's INDV Position: Q2 2026 in Review

Fuller & Thaler Asset Management increased its Indivior Pharmaceuticals (INDV) stake by 1.9% in Q2 2026, buying an estimated $3.13M and bringing the position to 4,615,816 shares worth $189M. The position accounts for 0.52% of the portfolio, ranked #56.

Fuller & Thaler Asset Management first reported a position in INDV in Q3 2025 and has held it in 4 quarters since. The position peaked at $229M in Q4 2025. 339 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Fuller & Thaler Asset Management held 4,615,816 shares of Indivior Pharmaceuticals worth $189M as of Q2 2026.
  • Fuller & Thaler Asset Management bought 86,233 Indivior Pharmaceuticals shares in Q2 2026, an estimated $3.13M.
  • Indivior Pharmaceuticals made up 0.52% of Fuller & Thaler Asset Management's portfolio in Q2 2026, its #56 holding.
  • Fuller & Thaler Asset Management first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Fuller & Thaler Asset Management's Indivior Pharmaceuticals position peaked at $229M in Q4 2025.
  • 339 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Fuller & Thaler Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.